Active — Not RecruitingNot Applicable

Global Registry: ExAblate Neuro MR Guided Focused Ultrasound (MRgFUS) of Neurological Disorders:

United States500 participantsStarted 2016-12

Plain-language summary

A global post approval study to collect safety and effectiveness data related to ExAblate Neuro for the treatment of certain disorders such as Essential Tremor, Parkinson's Movement Disorders, or Neuropathic Pain within the thalamus and/or pallidum.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Meets labeling indication for use per information for prescribers * Target is accessible by Focused Ultrasound per treatment planning parameters Exclusion Criteria: * Do not agree to participate or who are unlikely to participate over an extended period of time

What they're measuring

Clinical Rating Scale for Tremor

Timeframe: 5 year

Trial details

NCT IDNCT03100474

SponsorInSightec

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2026-06

View on ClinicalTrials.gov More Essential Tremor trials